← Back to Dashboard

Gemcitabine

Antimetabolite; Nucleoside analog

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F
SDUQYLNIPVEERB-QPPQHZFASA-N

Clinical Development by Virus14

Influenza A virus
FLUAV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Hepacivirus C
HCV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
EV-A71
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus B
CVB-3
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus C
PV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human immunodeficiency virus 1
HIV-1
Target: Viral RT
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rhinovirus A
HRV-A1B
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 1
HSV-1
Target: Viral DNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Sindbis virus
SINV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Vaccinia virus
VACV
Target: Viral DNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zika virus
ZIKV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved